This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laganas, V.
Right arrow Articles by Silverman, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laganas, V.
Right arrow Articles by Silverman, J. A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 2003, p. 2682-2684, Vol. 47, No. 8
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.8.2682-2684.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

In Vitro Bactericidal Activities of Daptomycin against Staphylococcus aureus and Enterococcus faecalis Are Not Mediated by Inhibition of Lipoteichoic Acid Biosynthesis

Valerie Laganas, Jeffrey Alder, and Jared A. Silverman*

Cubist Pharmaceuticals, Inc., Lexington, Massachusetts

Received 23 December 2002/ Returned for modification 17 March 2003/ Accepted 7 May 2003

Previous studies have suggested that lipoteichoic acid biosynthesis inhibition is the mechanism of action of daptomycin. In this investigation, daptomycin inhibited all macromolecular synthesis in Staphylococcus aureus, Enterococcus faecalis, and Enterococcus hirae without kinetic or dose specificity for lipoteichoic acid. Daptomycin remained bactericidal in the absence of ongoing lipoteichoic acid synthesis. Inhibition of lipoteichoic acid synthesis is apparently not the mechanism of action of daptomycin in these pathogens.

* Corresponding author. Mailing address: Cubist Pharmaceuticals, Inc., 65 Hayden Ave., Lexington, MA 02421. Phone: (781) 860-8405. Fax: (781) 861-1164. E-mail: jared.silverman{at}cubist.com.

Antimicrobial Agents and Chemotherapy, August 2003, p. 2682-2684, Vol. 47, No. 8
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.8.2682-2684.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Mave, V., Garcia-Diaz, J., Islam, T., Hasbun, R. (2009). Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?. J Antimicrob Chemother 64: 175-180 [Abstract] [Full Text]  
  • Hachmann, A.-B., Angert, E. R., Helmann, J. D. (2009). Genetic Analysis of Factors Affecting Susceptibility of Bacillus subtilis to Daptomycin. Antimicrob. Agents Chemother. 53: 1598-1609 [Abstract] [Full Text]  
  • Hawkey, P. M. (2008). Pre-clinical experience with daptomycin. J Antimicrob Chemother 62: iii7-iii14 [Abstract] [Full Text]  
  • Muthaiyan, A., Silverman, J. A., Jayaswal, R. K., Wilkinson, B. J. (2008). Transcriptional Profiling Reveals that Daptomycin Induces the Staphylococcus aureus Cell Wall Stress Stimulon and Genes Responsive to Membrane Depolarization. Antimicrob. Agents Chemother. 52: 980-990 [Abstract] [Full Text]  
  • Mascio, C. T. M., Alder, J. D., Silverman, J. A. (2007). Bactericidal Action of Daptomycin against Stationary-Phase and Nondividing Staphylococcus aureus Cells. Antimicrob. Agents Chemother. 51: 4255-4260 [Abstract] [Full Text]  
  • Grundling, A., Schneewind, O. (2007). Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 104: 8478-8483 [Abstract] [Full Text]  
  • Cui, L., Tominaga, E., Neoh, H.-m., Hiramatsu, K. (2006). Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 50: 1079-1082 [Abstract] [Full Text]  
  • Kosowska, K., Hoellman, D. B., Lin, G., Clark, C., Credito, K., McGhee, P., Dewasse, B., Bozdogan, B., Shapiro, S., Appelbaum, P. C. (2005). Antipneumococcal Activity of Ceftobiprole, a Novel Broad-Spectrum Cephalosporin. Antimicrob. Agents Chemother. 49: 1932-1942 [Abstract] [Full Text]  
  • Streit, J. M., Steenbergen, J. N., Thorne, G. M., Alder, J., Jones, R. N. (2005). Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis. J Antimicrob Chemother 55: 574-578 [Abstract] [Full Text]  
  • Kulanthaivel, P., Kreuzman, A. J., Strege, M. A., Belvo, M. D., Smitka, T. A., Clemens, M., Swartling, J. R., Minton, K. L., Zheng, F., Angleton, E. L., Mullen, D., Jungheim, L. N., Klimkowski, V. J., Nicas, T. I., Thompson, R. C., Peng, S.-B. (2004). Novel Lipoglycopeptides as Inhibitors of Bacterial Signal Peptidase I. J. Biol. Chem. 279: 36250-36258 [Abstract] [Full Text]  
  • Silverman, J. A., Perlmutter, N. G., Shapiro, H. M. (2003). Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus. Antimicrob. Agents Chemother. 47: 2538-2544 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»